Florenzo Iannone
Florenzo Iannone
professore reumatologia
Verified email at
Cited by
Cited by
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ...
Annals of the rheumatic diseases 69 (10), 1809-1815, 2010
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ...
Annals of the rheumatic diseases 74 (6), 1188-1194, 2015
Mapping and predicting mortality from systemic sclerosis
M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ...
Annals of the rheumatic diseases 76 (11), 1897-1905, 2017
The pathophysiology of osteoarthritis
F Iannone, G Lapadula
Aging clinical and experimental research 15 (5), 364-372, 2003
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the …
F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ...
Autoimmunity reviews 12 (2), 225-229, 2012
Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes
F Iannone, C De Bari, F Dell'Accio, M Covelli, V Patella, G Lo Bianco, ...
Rheumatology 41 (12), 1413-1418, 2002
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis
G Giannelli, R Erriquez, F Iannone, F Marinosci, G Lapadula, S Antonaci
Clinical and experimental rheumatology 22 (3), 335-338, 2004
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
LK Mercer, J Askling, P Raaschou, WG Dixon, L Dreyer, ML Hetland, ...
Annals of the rheumatic diseases 76 (2), 386-391, 2017
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice
F Cantini, C Nannini, L Niccoli, F Iannone, G Delogu, G Garlaschi, ...
Autoimmunity reviews 14 (6), 503-509, 2015
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
M Elhai, M Boubaya, O Distler, V Smith, M Matucci-Cerinic, JJA Sancho, ...
Annals of the rheumatic diseases 78 (7), 979-987, 2019
Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study
L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo, F Franceschini, ...
Medicine 94 (32), 2015
Obesity and inflammation-targets for OA therapy
F Iannone, G Lapadula
Current drug targets 11 (5), 586-598, 2010
Digital ulcers predict a worse disease course in patients with systemic sclerosis
C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ...
Annals of the rheumatic diseases 75 (4), 681-686, 2016
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ...
Annals of the rheumatic diseases 75 (1), 103-109, 2016
Use of etanercept in the treatment of dermatomyositis: a case series.
F Iannone, C Scioscia, PCF Falappone, M Covelli, G Lapadula
The Journal of rheumatology 33 (9), 1802-1804, 2006
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors
F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ...
The Journal of rheumatology 39 (6), 1179-1184, 2012
Laser-evoked potentials habituation in fibromyalgia
M de Tommaso, A Federici, R Santostasi, R Calabrese, E Vecchio, ...
The journal of pain 12 (1), 116-124, 2011
Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes
F Iannone, C De Bari, F Dell Accio, M Covelli, FP Cantatore, V Patella, ...
Clinical and experimental rheumatology 19 (2), 139-146, 2001
Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry …
JE Gottenberg, DS Courvoisier, MV Hernandez, F Iannone, E Lie, ...
Arthritis & rheumatology 68 (6), 1346-1352, 2016
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives
G Lopalco, L Cantarini, A Vitale, F Iannone, MG Anelli, L Andreozzi, ...
Mediators of inflammation 2015, 2015
The system can't perform the operation now. Try again later.
Articles 1–20